Bottle 20 ml.
Rinorus – belongs to the group of local vasoconstrictors (decongestants) with alpha-adrenomimetic activity, causes narrowing of the blood vessels of the nasal mucosa, eliminating edema and hyperemia of the nasal mucosa, restores nasal passages, facilitates nasal passage.
The action of the drug occurs a few minutes after its use and lasts up to 10 hours
acute rhinitis (including acute respiratory infections)
allergic rhinitis (if there is no allergy to eucalyptus oil)
sinusitis (sinusitis, frontal sinusitis)
otitis media (as part of combination therapy to reduce swelling of the mucous membrane of the nasopharynx).
Do not use for a long time, for example, with chronic rhinitis.
In dosages exceeding recommended, may affect the ability to drive a vehicle or equipment.
1 ml contains:
Active ingredient: xylometazoline hydrochloride 1 mg
Excipients: benzalkonium chloride, sodium chloride, disodium edetate, sodium dihydrogen phosphate dihydrate, sodium hydrogen phosphate dodecahydrate and oil.
Dosage and administration
Adults and children over 6 years old are given 2-3 injections of a 0.1% solution of Rinorus in each nasal passage 3-4 times a day.
Do not use more than 3 times a day.
Do not use the drug without a break for more than 3-5 days.
Local reactions: with frequent and / or prolonged use – irritation and / or dryness of the mucous membrane of the nasopharynx, burning, paresthesia, sneezing, hypersecretion rarely – swelling of the nasal mucosa.
Systemic reactions: vomiting, headache, palpitations, increased blood pressure, insomnia, visual impairment, depression (with prolonged use of high doses).
It is possible to enhance systemic effects while using MAO inhibitors and tricyclic antidepressants.
Symptoms: increased side effects.
Treatment: symptomatic under the supervision of a physician.
In a dry, dark place at 15 to 25 ° C.
Keep out of the reach and sight of children.
Conditions for dispensing from pharmacies
Without a prescription
Synthesis AKOMP, Russia